Table 2.
Summary of smoking outcomes from the iQuit in Practice pilot trial.
Smoking outcomes for the iQuit in Practice pilot trial | Control arm, n (%) | Intervention arm, n (%) | Absolute difference, % (95% CI) | Odds ratio (95% CI) | |
Primary outcome | |||||
|
Self-reported 2-week point-prevalence abstinence at 8-week follow-up | 122 (40.3) | 135 (45.2) | 4.9 (−3.0 to 12.7) | 1.22 (0.88 to 1.69) |
Secondary outcomes | |||||
|
Carbon monoxide–verified 2-week point-prevalence abstinence at 4-week follow-up after quit date | 71 (23) | 81 (27) | 3.7 (−3.3 to 10.6) | 1.21 (0.84 to 1.76) |
|
Self-reported 3-month prolonged abstinence at 6-month follow-up | 70 (23) | 76 (25) | 2.3 (−4.5 to 9.1) | 1.13 (0.78 to 1.65) |
Additional outcomes | |||||
|
Self-reported 6-month prolonged abstinence at 6-month follow-up | 27 (9) | 45 (15) | 6.1 (0.9 to 11.4) | 1.81 (1.09 to 3.01) |
|
Continuous abstinence (4-week, 8-week, and 6-month follow-ups) | 19 (6) | 34 (11) | 5.1 (0.6 to 9.8) | 1.92 (1.07 to 3.45) |